… further applications of the Axiomer platform to unlock new innovative treatments for people living with diseases with … developing the medicines of tomorrow takes time, sustained innovation and most importantly, collaboration,” said Andrew … better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our …
… that is independently developing and commercializing innovative RNA medicines for patients who suffer from IRDs. … will allow us to more efficiently turn our scientific innovation into multiple potentially life-changing medicines …